Skip to main content
Why ProtoVela
Section · N° 04

The advantages of computational-first biotech

ProtoVela was founded on a simple belief: the next wave of protein innovation will be designed, not just discovered. Here's why partners choose us.

01

AI-native methodology

Built around modern machine learning, not retrofitted onto legacy workflows.

02

Deep scientific roots

Founded by a scientist with decades of experience in membrane proteins, VDAC structural analysis, X-ray crystallography and protein chemistry.

03

Cost-efficient

No wet-lab overhead — predictive in silico work dramatically reduces cost per iteration.

04

Faster timelines

Reducing wet lab iterations through in silico design — iterate in days, not months. Move from concept to validated design at startup speed.

05

Tangible deliverables

Designs that translate — ready for your team to express, test and validate.

06

Trusted partnership

Transparent collaboration, clear documentation and full IP ownership in generative protein design — all rights remain with the customer.

The Promise

We help you overcome one of biotech's biggest hurdles — protein stability.

With ProtoVela, your proteins become market-ready faster and more reliable. We bring your most challenging molecules into the realm of the possible.

Optimization Targets

Six protein properties we target by design

Every ProtoVela design pipeline can be tuned toward the parameters that matter most for your molecule and your market.

01

Producibility

Higher recombinant expression yield through sequence optimization in the appropriate host system — fewer batches, lower cost per gram of protein.

02

Colloidal stability

Reduced aggregation and improved behaviour at high concentrations for formulation and storage.

03

Thermal stability

Elevated melting temperature (Tm) — proteins that survive process, transport and shelf conditions.

04

Long-term stability

Engineered for extended shelf life under realistic storage conditions.

05

Proteolytic stability

Resistance to enzymatic degradation — critical for in vivo half-life and downstream processing.

06

Patentability

Sequence space designed for clean IP — distinct from prior art and ready for protection.

Design Process

Our 8-step design strategy

A structured pipeline from client sequence to delivered candidate set — fully in silico, ready for wet-lab validation.

  1. STEP · 01
    01

    Sequence analysis

    In-depth assessment of the client's target sequence and project goals.

  2. STEP · 02
    02

    Structural search

    Identification of related and homologous structures from public and proprietary databases.

  3. STEP · 03
    03

    De novo generation

    Generation of candidate de novo structures where no suitable template exists.

  4. STEP · 04
    04

    Residue selection

    Identification of critical residues — catalytic, structural, interface and stability hotspots.

  5. STEP · 05
    05

    AI-driven optimization

    Sequence optimization combining generative models, evolutionary signal and physics-based scoring.

  6. STEP · 06
    06

    Computation & analysis

    In silico validation of each design — energetics, dynamics and predicted properties.

  7. STEP · 07
    07

    Success assessment

    Ranking of designs against the original target profile and feasibility criteria.

  8. STEP · 08
    08

    Selection for DSP

    Curated set of sequences delivered for cloning, expression and downstream processing.

01
Data-driven insights

Limitless computational power applied to molecular discovery.

02
100%
Focus on innovation

Entirely in silico approaches — no wet lab dependencies.

03
30+
Years scientific experience

Combined leadership rooted in protein science and structural biology.

Let's collaborate

Your gateway to more stable, optimized proteins.

We help you overcome one of biotech's biggest hurdles — protein stability. With ProtoVela's in silico stability optimization and in silico drug discovery partnerships, your proteins become market-ready faster and more reliable.